3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Breast Neoplasms
1
Interventions
Carboplatin
4
durvalumab
2
Paclitaxel
2
selpercatinib
1
repotrectinib
1
pembrolizumab
1
aflutinib
1
Pemetrexed
1
Nivolumab
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Respiratory Tract Neoplasms
×
patritumab
×
90 days
×
Clear all
No trials found.